Serán BioScience is a Contract Development and Manufacturing Organization (CDMO) founded in 2016 and based in Bend, Oregon. The company provides comprehensive drug product development, formulation, and manufacturing services for pharmaceutical and biotechnology clients, taking projects from discovery through clinical trials and commercial manufacturing.
The firm's technical capabilities span particle engineering, spray drying, hot melt extrusion, amorphous solid dispersions, lipid formulations, micronization, and nano-milling, among other advanced solid dosage form technologies. Its formulation services focus on overcoming bioavailability and solubility challenges, while its manufacturing operations include cGMP clinical production of versatile solid dosage forms.
Serán BioScience operates with a science-first methodology and maintains deep regulatory knowledge. The company has secured a $200 million strategic growth investment to support its operations and expansion.
